Ronald L Moy
Overview
Explore the profile of Ronald L Moy including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
65
Citations
411
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Levy T, Lerman I, Waibel J, Gauglitz G, Clementoni M, Friedmann D, et al.
Lasers Surg Med
. 2024 Oct;
57(1):15-26.
PMID: 39434507
Background: For three decades, fractional ablative CO lasers have been used for skin rejuvenation. With breakthroughs in laser technology and expanding popularity, new recommendations and suggestions arise on a regular...
2.
Schneider J, Majidian M, Moy R
Cureus
. 2023 Oct;
15(8):e44403.
PMID: 37791183
Introduction Nicotinamide (Vitamin B3) has been shown to reduce the rate of non-melanoma skin cancers by 23%, yet most patients do not know that this supplement reduces skin cancer. Understanding...
3.
Schneider J, Mamelak A, Tejani I, Jarmain T, Moy R
J Drugs Dermatol
. 2023 Jul;
22(7):647-652.
PMID: 37410051
Background: Triage of patients with skin diseases often includes an initial assessment by a nurse or general practitioner, followed by a dermatologist. Artificial intelligence (AI) systems have been reported to...
4.
Anderson J, Tejani I, Jarmain T, Kellett L, Moy R
Cutis
. 2023 Jul;
111(5):254-258.
PMID: 37406330
Early diagnosis of melanoma drastically reduces morbidity and mortality; however, most skin lesions are not initially evaluated by dermatologists, and some patients may require a referral. This study sought to...
5.
Mitchell K, Moy R
Aesthet Surg J
. 2023 Mar;
43(7):NP541-NP543.
PMID: 36928876
No abstract available.
6.
Ross A, Schlesinger T, Harmon C, Moy R, Rohrer T, Mehregan D, et al.
Front Oncol
. 2022 Dec;
12:1044694.
PMID: 36531070
Background: Nano-Pulse Stimulation™ (NPS™) therapy is a new, non-thermal bioelectric modality that applies ultrashort pulses of electric energy to trigger regulated cell death (RCD) in treated tissues. Instead of initiating...
7.
Anderson J, Moy L, Moy R
Dermatol Clin
. 2022 Nov;
41(1):231-238.
PMID: 36410981
Chemoprophylaxis against nonmelanoma skin cancer (NMSC) should be considered in high-risk populations such as those with certain genetic disorders, immunosuppressive states, chronic radiation, excessive UV exposure, or extensive personal or...
8.
Lorenc Z, Adelglass J, Avelar R, Baumann L, Beer K, Cohen J, et al.
Aesthet Surg J
. 2021 Jun;
41(12):1494-1495.
PMID: 34189562
No abstract available.
9.
Lorenc Z, Adelglass J, Avelar R, Baumann L, Beer K, Cohen J, et al.
Aesthet Surg J
. 2021 May;
41(12):1423-1438.
PMID: 33944913
Background: PrabotulinumtoxinA is a 900-kDa botulinum toxin type A produced by Clostridium botulinum. Objectives: The authors sought to investigate the safety of prabotulinumtoxinA for treatment of glabellar lines. Methods: This...
10.
Majidian M, Kolli H, Moy R
Int J Dermatol
. 2021 Mar;
60(12):1481-1487.
PMID: 33739464
Background: Hormone replacement therapy and various devices exist to treat signs of aging, such as skin thinning, yet there are no reviews summarizing or evaluating their role in neocollagenesis and...